The Full Spectrum of News.
Get Started
SubscribeLogin
Israel-Hamas Conflict
Conclave
Pope Francis
Met Gala
Mother's Day
Airstrike
Artificial Intelligence
Social Media
Champions League
European Union
Catholic Church
Vatican
Education
Published • loading... • Updated

Atara Biotherapeutics Provides Regulatory Updates on EBVALLO™ (tabelecleucel)

Summary by Hastings Tribune
THOUSAND OAKS, Calif.--(BUSINESS WIRE)--May 5, 2025-

2 Articles

All
Left
Center
1
Right
Hastings TribuneHastings Tribune
Center

Atara Biotherapeutics Provides Regulatory Updates on EBVALLO™ (tabelecleucel)

THOUSAND OAKS, Calif.--(BUSINESS WIRE)--May 5, 2025-

Read Full Article
stocktitan.netstocktitan.net

FDA Clears Atara's EBVALLO Trials to Resume After Hold, Sets Key Meeting for Cancer Drug Approval Path

Atara can now restart Phase 3 ALLELE study and Phase 2 expansion trial for EBVALLO cancer therapy. FDA grants Type A meeting to discuss BLA path. Learn more.

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources are Center
100% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

stocktitan.net broke the news in on Monday, May 5, 2025.
Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

Cancer

Cancer

Thousand Oaks

Thousand Oaks

News
For You
SearchBlindspotLocal